metaEvidence - overview


			deaths (OS)	progression or deaths (PFS)	RFS/DFS
metastatic/advanced RCC (mRCC) - (neo)adjuvant(NA) metastatic/advanced RCC (mRCC) - (neo)adjuvant(NA)
versus placebo
	pembrolizumab alone vs. placebo	1	-300 [-573; -26] /10000 18/496 vs. 33/498	-	NaN [NaN; NaN] /10000 0/0 vs. 0/0